SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-001571
Filing Date
2020-02-27
Accepted
2020-02-27 11:50:26
Documents
121
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adap-20191231x10kb99908.htm   iXBRL 10-K 2916041
2 EX-4.4 ex-4d4.htm EX-4.4 163456
3 EX-10.4 ex-10d4.htm EX-10.4 888592
4 EX-10.5 ex-10d5.htm EX-10.5 2105740
5 EX-10.6 ex-10d6.htm EX-10.6 55648
6 EX-23.1 ex-23d1.htm EX-23.1 5624
7 EX-31.1 ex-31d1.htm EX-31.1 17264
8 EX-31.2 ex-31d2.htm EX-31.2 17253
9 EX-32.1 ex-32d1.htm EX-32.1 7096
10 EX-32.2 ex-32d2.htm EX-32.2 7095
11 GRAPHIC adap-20191231x10kb99908001.jpg GRAPHIC 22447
  Complete submission text file 0001558370-20-001571.txt   15702979

Data Files

Seq Description Document Type Size
12 EX-101.SCH adap-20191231.xsd EX-101.SCH 85331
13 EX-101.CAL adap-20191231_cal.xml EX-101.CAL 76446
14 EX-101.DEF adap-20191231_def.xml EX-101.DEF 286600
15 EX-101.LAB adap-20191231_lab.xml EX-101.LAB 704552
16 EX-101.PRE adap-20191231_pre.xml EX-101.PRE 559970
61 EXTRACTED XBRL INSTANCE DOCUMENT adap-20191231x10kb99908_htm.xml XML 2453344
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37368 | Film No.: 20659713
SIC: 2836 Biological Products, (No Diagnostic Substances)